4-hydroxynonenal in the pathogenesis and progression of human diseases

Current Medicinal Chemistry

Volumn 21, Issue 2, 2014, Pages 230-237

  Shoeb, Mohammad ^a   Ansari, Naseem H ^a   Srivastava, Satish K ^a   Ramana, Kota V ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

4 Hydroxy 2 nonenal; Alzheimer; Cancer; Cataract; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; ARACHIDONIC ACID; GLUTATHIONE; HYDROPEROXIDE; LINOLEIC ACID; MALONALDEHYDE; 4-HYDROXY-2-NONENAL; ALDEHYDE;

AGING; ALCOHOL LIVER DISEASE; ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CATARACT; CELL DEATH; CELL DIFFERENTIATION; CHEMICAL STRUCTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLON CANCER; DIABETES MELLITUS; DISEASE COURSE; DNA DAMAGE; ENDOTOXEMIA; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; KIDNEY CANCER; LIPID PEROXIDATION; METABOLIC REGULATION; NEOPLASM; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; RETINA MACULA AGE RELATED DEGENERATION; RHEUMATOID ARTHRITIS; SECOND MESSENGER; INFLAMMATORY BOWEL DISEASE; METABOLISM; PATHOLOGY;

ALDEHYDES; ALZHEIMER DISEASE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DISEASE PROGRESSION; HUMANS; INFLAMMATORY BOWEL DISEASES; LIPID PEROXIDATION; MOLECULAR STRUCTURE; NEOPLASMS;

EID: 84893273332     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113209990181     Document Type: Article

References (131)

1. Halliwell, B.; Gutteridge, J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Meth. Enzymol., 1990, 186, 1-85.
2. Poli, G.; Schaur, J. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life, 2000, 50, 315-321.
3. Uchida, K.; Stadtman, E.R. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc. Natl. Acad. Sci. USA., 1992, 89, 4544-4589.
4. Carletto, C.; Nicolaÿ, J.F.; Courbebaisse, Y. Oxidative stress and cutaneous ageing: the 'toxic second messengers' concept and an interesting family of products, 'pseudodipeptides'. Int. J. Cosmet. Sci., 2000, 22, 361-370.
5. Esterbauer, H.; Schaur, R.J.; Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med., 1991, 11, 81-128.
6. Harold, W. Gardner. Oxygen radical chemistry of polyunsaturated fatty acids. Free Radic. Biol. Med., 1989, 7, 65-86.
7. Petersen, D.R.; Doorn, J.A. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic. Biol. Med., 2004, 37, 937-945.
8. Awasthi, Y.C.; Sharma, R.; Sharma, A.; Yadav, S.; Singhal, S.S.; Chaudhary, P.; Awasthi, S. Self-regulatory role of 4- hydroxynonenal in signaling for stress-induced programmed cell death. Free Radic. Biol. Med., 2008, 45, 111-118.
9. Uchida, K.; Kumagai, T. 4-Hydroxy-2-nonenal as a COX-2 inducer. Mol. Aspects Med., 2003, 24, 213-218.
10. Zarkovic, K. 4-Hydroxynonenal and neurodegenerative diseases. Mol. Aspects Med., 2003, 24, 293-303.
11. Poli, G.; Dianzani, M.U.; Cheeseman, K.H.; Slater, T.F.; Lang, J.; Esterbauer, H. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem. J., 1985, 227, 629-638.
12. Koster, J.F.; Slee, R.G.; Montfoort, A.; Lang, J.; Esterbauer, H. Comparison of the inactivation of glucose-6-phosphatase by in situ lipid peroxidation-derived 4-hydroxynonenal and exogenous 4- hydroxynonenal. Free Radic. Res. Commun., 1986, 1(4), 273-287.
13. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol., 2007, 39, 44-84.
14. Guichardant, M.; Taibi-Tronche, P.; Fay, L.B.; Lagarde, M. Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Radic. Biol. Med., 1998, 9, 1049-1056.
15. Vazdar, M.; Jurkiewicz, P.; Hof, M.; Jungwirth, P.; Cwiklik, L. Behavior of 4 hydroxynonenal in phospholipid membranes. J. Phys. Chem. B., 2012, 116, 6411-6415.
16. Hammer, A.; Ferro, M.; Tillian, H.M.; Tatzber, F.; Zollner, H.; Schauenstein, E.; Schaur, R.J. Effect of oxidative stress by iron on 4-hydroxynonenal formation and proliferative activity in hepatomas of different degrees of differentiation. Free Radic. Biol. Med., 1997, 23, 26-33.
17. Poli, G.; Schaur, R.J. 4-Hydroxynonenal in the Pathomechanisms of Oxidative Stress. IUBMB. Life., 2000, 50, 315-321.
18. Schaur, R.J. Basic aspects of the biochemical reactivity of 4- hydroxynonenal. Mol. Aspects Med., 2003, 24, 149-159.
19. Poli, G.; Biasi, F.; Leonarduzzi, G. 4-Hydroxynonenal-protein adducts: A reliable biomarker of lipid oxidation in liver diseases. Mol. Aspects Med., 2008, 29, 67-71.
20. Wakita, C.; Maeshima, T.; Yamazaki, A.; Shibata, T.; Ito, S.; Akagawa, M.; Ojika, M.; Yodoi, J.; Uchida, K. Stereochemical configuration of 4-hydroxy-2-nonenal-cysteine adducts and their stereoselective formation in a redox-regulated protein. J. Biol. Chem., 2009, 284, 28810-28822.
21. LoPachin, R.M.; Gavin, T.; Petersen, D.R.; Barber, D.S. Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chem. Res. Toxicol., 2009, 22, 1499-1508.
22. Poli, G.; Schaur, R.J. 4-Hydroxynonenal in the Pathomechanisms of Oxidative Stress. IUBMB Life, 2000, 50, 315-321.
23. Engle, M.R.; Singh, S.P.; Czernik, P.J.; Gaddy, D.; Montague, D.C.; Ceci, J.D.; Yang, Y.; Awasthi, S.; Awasthi, Y.C.; Zimniak, P. Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: generation and analysis of mGSTA4 null mouse. Toxicol. Appl. Pharmacol., 2004, 194, 296-308.
24. Witz, G. Biological interactions of α, β-unsaturated aldehydes. Free Radic. Biol. Med., 1989, 7, 333-349.
25. Esterbauer, H.; Cheeseman K.H. Determination of aldehydic lipid peroxidation products; malonaldehyde and 4-hydroxynonenal. Methods Enzymol., 1990, 186, 407-421.
26. Parola, M.; Bellomo, G.; Robino, G.; Barrera, G.; Dianzani, M. U. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxid. Redox Signal., 1999, 1, 255-284.
27. Spiteller, P.; Kern, W.; Reiner, J.; Spiteller, G. Aldehydic lipid peroxidation products derived from linoleic acid. Biochim. Biophys. Acta., 2001, 1531, 188-208.
28. Michiels, C.; Remacle, J. Cytotoxicity of linoleic acid peroxide, malondialdehyde and 4-hydroxynonenal towards human fibroblasts. Toxicology, 1991, 66, 225-234.
29. Griesser, M.; Boeglin, W.E.; Suzuki, T.; Schneider, C. Convergence of the 5-LOX and COX-2 pathways: heme-catalyzed cleavage of the 5S-HETE-derived di-endoperoxide into aldehyde fragments. J. Lipid Res., 2009, 50, 2455-2462.
30. Jomova, K.; Valko, M. Advances in metal-induced oxidative stress and human disease. Toxicology, 2011, 283, 65-87.
31. Valko, M.; Morris, H.; Cronin, M.T. Metals, toxicity and oxidative stress. Curr. Med. Chem., 2005, 12, 1161-1208.
32. Zhang, M.; Shoeb, M.; Goswamy, J.; Liu, P.; Xiao, T.L.; Hogan, D.; Campbell, G.A.; Ansari, N.H. Overexpression of aldehyde dehydrogenase 1A1 reduces oxidation-induced toxicity in SH-SY5Y neuroblastoma cells. J. Neurosci. Res., 2010, 88, 686-694.
33. Xiao, T.; Shoeb, M.; Siddiqui, M.S.; Zhang, M.; Ramana, K.V.; Srivastava, S.K.; Vasiliou, V.; Ansari, N.H. Molecular cloning and oxidative modification of human lens ALDH1A1: implication in impaired detoxification of lipid aldehydes. J. Toxicol. Environ. Health A., 2009, 72, 577-584.
34. Balogh, L.M; Atkins, W.M. Interactions of glutathione transferases with 4-hydroxynonenal. Drug Metab. Rev., 2011, 43, 165-178.
35. Ramana, K.V.; Fadl, A.A.; Tammali, R.; Reddy, A.B.; Chopra, A.K.; Srivastava, S.K. Aldose reductase mediates the lipopolysaccharide- induced release of inflammatory mediators in RAW264.7 murine macrophages. J. Biol. Chem., 2006, 281, 33019-33029.
36. Ramana, K.V.; Bhatnagar, A.; Srivastava, S.; Yadav, U.C.; Awasthi, S.; Awasthi, Y.C.; Srivastava, S.K. Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductasecatalyzed reduction of the HNE-glutathione conjugates in regulating cell growth. J. Biol. Chem., 2006, 281, 17652-17660.
37. Vatsyayan, R.; Lelsani, P.C.; Chaudhary, P.; Kumar, S.; Awasthi, S.; Awasthi, Y.C. The expression and function of vascular endothelial growth factor in retinal pigment epithelial (RPE) cells is regulated by 4-hydroxynonenal (HNE) and glutathione StransferaseA4- 4. Biochem. Biophys. Res. Commun., 2012, 417, 346-351.
38. Almeida, M.; Ambrogini, E.; Han, L.; Manolagas, S.C.; Jilka, R.L. Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. J. Biol. Chem., 2009, 284, 27438-27448.
39. Singh, S.P.; Chen, T.; Chen, L.; Mei, N.; McLain, E.; Samokyszyn, V.; Thaden, J.J.; Moore, M.M.; Zimniak, P. Mutagenic effects of 4- hydroxynonenal triacetate, a chemically protected form of the lipid peroxidation product 4-hydroxynonenal, as assayed in L5178Y/Tk+/- mouse lymphoma cells. J. Pharmacol. Exp. Ther., 2005, 313, 855-861.
40. Manini, P.; Napolitano, A.; Camera, E.; Caserta, T.; Picardo, M.; Palumbo, A.; d'Ischia, M. Ni2+ enhances Fe2+/peroxide-induced oxidation of arachidonic acid and formation of geno/cytotoxic 4- hydroxynonenal: a possible contributory mechanism in nickel toxicity and allergenicity. Biochim. Biophys. Acta., 2003, 1621, 9-16.
41. Brambilla, G.; Sciabà, L.; Faggin, P.; Maura, A.; Marinari, U.M.; Ferro, M.; Esterbauer, H. Cytotoxicity, DNA fragmentation and sister-chromatid exchange in Chinese hamster ovary cells exposed to the lipid peroxidation product 4-hydroxynonenal and homologous aldehydes. Mutat. Res., 1986, 171, 169-176.
42. Chandra, A.; Srivastava, S.K. A synthesis of 4-hydroxy-2- trans - nonenal and 4-(3H) 4-hydroxy-2- trans -nonenal. Lipids, 1997, 32, 779-782.
43. Vigh, L.; Smith, R.G.; Soós, J.; Engelhardt, J.I.; Appel, S.H.; Siklós, L. Sublethal dose of 4-hydroxynonenal reduces intracellular calcium in surviving motor neurons in vivo. Acta Neuropathol., 2005, 109, 567-575.
44. Poli, G.; Leonarduzzi, F.; Biasi, E. Chiarpotto. Oxidative stress and cell signalling. Curr. Med. Chem., 2004, 11, 1163-1182.
45. Wang, S.; Kotamraju, S.; Konorev, E.; Kalivendi, S.; Joseph, J.; Kalyanaraman, B. Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide. Biochem. J., 2002, 367, 729-740.
46. Siow, R.C.; Ishii, T.; Mann, G.E. Modulation of antioxidant gene expression by 4-hydroxynonenal: atheroprotective role of the Nrf2/ARE transcription pathway. Redox Rep., 2007, 12, 11-15.
47. Yehualaeshet, T.; O'Connor, R.; Green-Johnson, J.; Mai, S.; Silverstein, R.; Murphy-Ullrich, J.E.; Khalil, N. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am. J. Pathol., 1999, 155, 841-851.
48. Leonarduzzi, G.; Chiarpotto, E.; Biasi, F.; Poli, G. 4- Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol. Nutr. Food Res., 2005, 49, 1044-1049.
49. Yadav, U.C.; Srivastava, S.K.; Ramana, K.V. Understanding the role of aldose reductase in ocular inflammation. Curr. Mol. Med., 2010, 10, 540-549.
50. Ramana, K.V.; Srivastava, S.K. Aldose reductase: a novel therapeutic target for inflammatory pathologies. Int. J. Biochem. Cell Biol., 2010, 42, 17-20.
51. Zarkovic, K. 4-hydroxynonenal and neurodegenerative diseases. Mol. Aspects Med., 2003, 24, 293-303.
52. Selley, M.L. (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. Free Radic. Biol. Med., 1998, 25, 169-174.
53. Newcombe, J.; Li, H.; Cuzner, M.L. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis. Neuropathol. Appl. Neurobiol., 1994, 20, 152-162.
54. Shiota, M.; Song, Y.; Takeuchi, A.; Yokomizo, A.; Kashiwagi, E.; Kuroiwa, K.; Tatsugami, K.; Uchiumi, T.; Oda, Y.; Naito, S. Antioxidant therapy alleviates oxidative stress by androgen deprivation and prevents conversion from androgen dependent to castration resistant prostate cancer. J. Urol., 2012, 187, 707-714.
55. Akude, E.; Zherebitskaya, E.; Roy Chowdhury, S.K.; Girling, K.; Fernyhough, P. 4-Hydroxy-2-nonenal induces mitochondrial dysfunction and aberrant axonal outgrowth in adult sensory neurons that mimics features of diabetic neuropathy. Neurotox Res., 2010, 17, 28-38.
56. Mukhopadhyay, P.; Horváth, B.; Kechrid, M.; Tanchian, G.; Rajesh, M.; Naura, A.S.; Boulares, A.H.; Pacher, P. Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury. Free Radic. Biol. Med., 2011, 51, 1774-1788.
57. Kumano-Kuramochi, M.; Shimozu, Y.; Wakita, C.; Ohnishi-Kameyama, M.; Shibata, T.; Matsunaga, S.; Takano-Ishikawa, Y.; Watanabe, J.; Goto, M.; Xie, Q.; Komba, S.; Uchida, K.; Machida, S. Identification of 4-hydroxy-2-nonenal- histidine adducts that serve as ligands for human lectin-like oxidized LDL receptor-1. Biochem. J., 2012, 442, 171-180.
58. Almeida, M.; Ambrogini, E.; Han, L.; Manolagas, S.C.; Jilka, R.L.; Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. J. Biol. Chem., 2009, 284, 27438-27448.
59. Srivastava, S.K.; Yadav, U.C.; Reddy, A.B.; Saxena, A.; Tammali, R.; Shoeb, M.; Ansari, N.H.; Bhatnagar, A.; Petrash, M.J.; Srivastava, S.; Ramana, K.V. Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders. Chem. Biol. Interact., 2011, 191, 330-338.
60. Zhang, M.; Shoeb, M.; Liu, P.; Xiao, T.; Hogan, D.; Wong, I.G.; Campbell, G.A.; Ansari, N.H. Topical metal chelation therapy ameliorates oxidation-induced toxicity in diabetic cataract. J. Toxicol. Environ. Health A., 2011, 74, 380-391.
61. Xiao, T.; Shoeb, M.; Siddiqui, M.S.; Zhang, M.; Ramana, K.V.; Srivastava, S.K.; Vasiliou, V.; Ansari, N.H. Molecular cloning and oxidative modification of human lens ALDH1A1: implication in impaired detoxification of lipid aldehydes. J. Toxicol. Environ. Health A., 2009, 72, 577-584.
62. Finkel, L.H. Neuroengineering models of brain disease. Annu. Rev. Biomed. Eng., 2000, 2, 577-606.
63. Hayashi, T.; Shishido, N.; Nakayama, K.; Nunomura, A.; Smith, M.A.; Perry, G.; Nakamura, M. Lipid peroxidation and 4-hydroxy- 2-nonenal formation by copper ion bound to amyloid-beta peptide. Free Radic. Biol. Med., 2007, 43, 1552-1559.
64. Lee, H.P.; Pancholi, N.; Esposito, L.; Previll, L.A.; Wang, X.; Zhu, X.; Smith, M.A.; Lee, H.G. Early induction of oxidative stress in mouse model of Alzheimer disease with reduced mitochondrial superoxide dismutase activity. PLoS One, 2012, 7, e28033.
65. Markesbery, W.R.; Lovell, M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging, 1998, 19, 33-36.
66. Lovell, M.A.; Ehmann, W.D.; Mattson, M.P.; Markesbery, W.R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging, 1997, 18, 457-461.
67. Ando, Y.; Brannstrom, T.; Uchida, K.; Nyhlin, N.; Näsman, B.; Suhr, O.; Yamashita, T.; Olsson, T.; El Salhy, M.; Uchino, M.; Ando, M.. Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid. J. Neurol. Sci., 1998, 156, 172-176.
68. Jomova, K.; Vondrakova, D.; Lawson, M.; Valko, M. Metals, oxidative stress and neurodegenerative disorders. Mol. Cell Biochem., 2010, 345, 91-104.
69. Kawaguchi-Niida, M.; Shibata, N.; Morikawa, S.; Uchida, K.; Yamamoto, T.; Sawada, T.; Kobayashi, M. Crotonaldehyde accumulates in glial cells of Alzheimer's disease brain. Acta Neuropathol., 2006, 111, 422-429.
70. Siems, W.G.; Hapner, S.J.; van Kuijk, F.J. 4-hydroxynonenal inhibits Na(+)-K(+)-ATPase. Free Radic. Biol. Med., 1996, 20, 215-223.
71. Mattson, M.P.; Chan, S.L. Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium, 2003, 34, 385-397.
72. Lu, C.; Chan, S.L.; Haughey, N.; Lee, W.T.; Mattson, M.P. Selective and biphasic effect of the membrane lipid peroxidation product 4-hydroxy-2,3-nonenal on N-methyl-D-aspartate channels. J. Neurochem., 2001, 78, 577-589.
73. Kelly, J.F.; Storie, K.; Skamra, C.; Bienias, J.; Beck, T.; Bennett, D.A. Relationship between Alzheimer's disease clinical stage and Gq/11 in subcellular fractions of frontal cortex. J. Neural. Transm., 2005, 112, 1049-1056.
74. Jankovic, J. Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry, 2008, 79, 368-376.
75. Coppedè, F.; Armani, C.; Bidia, D.D.; Petrozzi, L.; Bonuccelli, U.; Migliore, L. Molecular implications of the human glutathione transferase A-4 gene (hGSTA4) polymorphisms in neurodegenerative diseases. Mutat. Res., 2005, 579, 107-114.
76. Qin, Z.; Hu, D.; Han, S.; Reaney, S.H.; Di Monte, D.A.; Fink, A.L. Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation. J. Biol. Chem., 2007, 282, 5862-5870.
77. Vatassery, G.T. Vitamin E and other endogenous antioxidants in the central nervous system. Geriatrics, 1998, 53, Suppl 1, S25-S27.
78. Klaunig, J.E.; Kamendulis, L.M. The role of oxidative stress in carcinogenesis. Ann. Rev. Pharmacol. Toxicol., 2004, 44, 239-267.
79. Marnett, L.J. Lipid peroxidation-DNA damage by malondialdehyde. Mutat. Res., 1999, 424, 83-95.
80. Marnett, L.J. Oxy radicals, lipid peroxidation and DNA damage. Toxicology, 2002, 181-182, 219-222.
81. Nair, U.; Bartsch, H.; Nair, J. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans. Free Radic. Biol. Med., 2007, 43, 1109-1120.
82. Bartsch, H.; Nair, J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch. Surg., 2006, 391, 499-510.
83. Oberley, T.D.; Toyokuni, S.; Szweda, L.I. Localization of hydroxynonenal protein adducts in normal human kidney and selected human kidney cancers. Free Radic. Biol. Med., 1999, 27, 695-703.
84. Zanetti, D.; Poli, G.; Vizio, B.; Zingaro, B.; Chiarpotto, E.; Biasi, F. 4-hydroxynonenal and transforming growth factor-beta1 expression in colon cancer. Mol. Aspects Med., 2003, 24, 273-280.
85. Skrzydlewska, E.; Sulkowski, S.; Koda, M.; Zalewski, B.; Kanczuga-Koda, L.; Sulkowska, M. Lipid peroxidation and antioxidant status in colorectal cancer. World J. Gastroenterol., 2005, 11, 403-406.
86. Skrzydlewska, E.; Stankiewicz, A.; Sulkowska, M.; Sulkowski, S.; Kasacka, I. Antioxidant status and lipid peroxidation in colorectal cancer. J. Toxicol. Environ. Health A., 2001, 64, 213-222.
87. Toyokuni, S.; Uchida, K.; Okamoto, K.; Hattori-Nakakuki, Y.; Hiai, H.; Stadtman, E.R. Formation of 4-hydroxy-2-nonenalmodified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc. Natl. Acad. Sci. USA, 1994, 91, 2616-2620.
88. Marquez-Quiñones, A.; Cipak, A.; Zarkovic, K.; Fattel-Fazenda, S.; Villa-Treviño, S.; Waeg, G.; Zarkovic, N.; Guéraud, F. HNEprotein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats. Free Radic. Res., 2010, 44, 119-127.
89. Chang, B.; Nishikawa, M.; Nishiguchi, S.; Inoue, M. L-carnitine inhibits hepatocarcinogenesis via protection of mitochondria. Int. J. Cancer, 2005, 113, 719-729.
90. Aldini, G.; Gamberoni, L.; Orioli, M.; Beretta, G.; Regazzoni, L.; Maffei Facino, R.; Carini, M. Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxytrans- 2-nonenal. J. Mass Spectrom., 2006, 41, 1149-1161.
91. Spies-Martin, D.; Sommerburg, O.; Langhans, C.D.; Leichsenring, M. Measurement of 4-hydroxynonenal in small volume blood plasma samples: modification of a gas chromatographic-mass spectrometric method for clinical settings. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2002, 774, 231-239.
92. Tammali, R.; Ramana, K.V.; Singhal, S.S.; Awasthi, S.; Srivastava, S.K. Aldose reductase regulates growth factor-induced cyclooxygenase- 2 expression and prostaglandin E2 production in human colon cancer cells. Cancer Res., 2006, 66, 9705-9713.
93. Tammali, R.; Ramana, K.V.; Srivastava, S.K. Aldose reductase regulates TNF-alpha-induced PGE2 production in human colon cancer cells. Cancer Lett., 2007, 252, 299-306.
94. Ramana, K.V.; Tammali, R.; Srivastava, S.K. Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells. Mol. Cancer Ther., 2010, 9, 813-824.
95. Tammali, R.; Reddy, A.B.; Saxena, A.; Rychahou, P.G.; Evers, B.M.; Qiu, S.; Awasthi, S.; Ramana, K.V.; Srivastava, S.K. Inhibition of aldose reductase prevents colon cancer metastasis. Carcinogenesis, 2011, 32, 1259-1267.
96. Cheng, J.Z.; Sharma, R.; Yang, Y.; Singhal, S.S.; Sharma, A.; Saini, M.K.; Singh, S.V.; Zimniak, P.; Awasthi, S.; Awasthi, Y.C. Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress. J. Biol. Chem., 2001, 276, 41213-41223.
97. Leake, K.; Singhal, J.; Nagaprashantha, L.D.; Awasthi, S.; Singhal, S.S. RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer. PLoS One, 2012, 7, e34582.
98. Hejtmancik, J.F. Congenital cataracts and their molecular genetics. Semin. Cell Dev. Biol., 2008, 19, 134-149.
99. Bron, A.J.; Brown, N.A. Perinuclear lens retrodots: a role for ascorbate in cataractogenesis. Br. J. Ophthalmol., 1987, 71, 86-95.
100. Gerido, D.A.; Sellitto, C.; Li, L.; White, T.W. Genetic background influences cataractogenesis, but not lens growth deficiency, in Cx50-knockout mice. Invest. Ophthalmol. Vis. Sci., 2003, 44, 2669-2674.
101. Aydin, B.; Yagci, R.; Yilmaz, F.M.; Erdurmus, M.; Karadaǧ, R.; Keskin, U.; Durmus, M.; Yigitoglu, R. Prevention of seleniteinduced cataractogenesis by N-acetylcysteine in rats. Curr. Eye Res., 2009, 34, 196-201.
102. Cekić, S.; Zlatanović, G.; Cvetković, T.; Petrović, B. Oxidative stress in cataractogenesis. Bosn. J. Basic Med. Sci., 2010, 10, 265-269.
103. Spector, A.; Wang, G.M.; Wang, R.R. Photochemically induced cataracts in rat lenses can be prevented by AL-3823A, a glutathione peroxidase mimic. Proc. Natl. Acad. Sci. USA, 1993, 90, 7485-7489.
104. Srivastava, S.K.; Awasthi, S.; Wang, L.; Bhatnagar, A.; Awasthi, Y.C.; Ansari, N.H. Attenuation of 4-hydroxynonenal-induced cataractogenesis in rat lens by butylated hydroxytoluene. Curr. Eye Res., 1996, 15, 749-754.
105. Ansari, N.H.; Wang, L.; Srivastava, S.K. Role of lipid aldehydes in cataractogenesis: 4-hydroxynonenal-induced cataract. Biochem. Mol. Med., 1996, 58, 25-30.
106. Choudhary, S.; Xiao, T.; Vergara, L.A.; Srivastava, S.; Nees, D.; Piatigorsky, J.; Ansari, N.H. Role of aldehyde dehydrogenase isozymes in the defense of rat lens and human lens epithelial cells against oxidative stress. Invest. Ophthalmol. Vis. Sci., 2005, 46, 259-267.
107. Subramaniam, R.; Roediger, F.; Jordan, B.; Mattson, M.P.; Keller, J.N.; Waeg, G.; Butterfield, D.A. The lipid peroxidation product, 4- hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins. J. Neurochem., 1997, 69, 1161-1169.
108. Fleuranceau-Morel, P.; Barrier, L.; Fauconneau, B.; Piriou, A.; Huguet, F. Origin of 4-hydroxynonenal incubation-induced inhibition of dopamine transporter and Na+/K+ adenosine triphosphate in rat striatal synaptosomes. Neurosci. Lett., 1999, 277, 91-94.
109. Yadav, U.C.; Ramana, K.V.; Awasthi, Y.C.; Srivastava, S.K. Glutathione level regulates HNE-induced genotoxicity in human erythroleukemia cells. Toxicol. Appl. Pharmacol., 2008, 227, 257-264.
110. Choudhary, S.; Xiao, T.; Srivastava, S.; Zhang, W,; Chan, L.L.; Vergara, L.A; Van Kuijk, F.J,; Ansari, N.H.; Toxicity and detoxification of lipid-derived aldehydes in cultured retinal pigmented epithelial cells. Toxicol Appl Pharmacol, 2005, 204, 122-134.
111. Schutt, F.; Bergmann, M.; Holz, F.G.; Kopitz, J. Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci., 2003, 44, 3663-3668.
112. Rahman, I.; van Schadewijk, A.A.; Crowther, A.J.; Hiemstra, P.S.; Stolk, J.; MacNee, W.; De Boer, W.I. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 2002, 166, 490-495.
113. Takimoto, T.; Yoshida, M.; Hirata, H.; Kashiwa, Y.; Takeda, Y.; Goya, S.; Kijima, T.; Kumagai, T.; Tachibana, I.; Kawase, I. 4- Hydroxy-2-nonenal induces chronic obstructive pulmonary disease- like histopathologic changes in mice. Biochem. Biophys. Res. Commun., 2012, 420, 84-90.
114. Hsieh, M.M.; Hegde, V.; Kelley, M.R.; Deutsch, W.A. Activation of APE/Ref-1 redox activity is mediated by reactive oxygen species and PKC phosphorylation. Nucleic Acids Res., 2001, 29, 3116-3122.
115. Lucey, M.R.; Mathurin, P.; Morgan, T.R. Alcoholic hepatitis. N Engl. J. Med., 2009, 360, 2758-2769.
116. Smathers, R.L.; Galligan, J.J.; Stewart, B.J.; Petersen, D.R. Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. Chem. Biol. Interact., 2011, 192, 107-112.
117. Kono, H.; Arteel, G.E.; Rusyn, I.; Sies, H.; Thurman, R.G. Ebselen prevents early alcohol-induced liver injury in rats. Free Radic. Biol. Med., 2001, 30, 403-411.
118. Tsukamoto, H.; Horne, W.; Kamimura, S.; Niemelä, O.; Parkkila, S.; Ylä-Herttuala, S.; Brittenham, G.M. Experimental liver cirrhosis induced by alcohol and iron. J. Clin. Invest., 1995, 96, 620-630.
119. Jaworek, J.; Leja-Szpak, A.; Nawrot-Porabka, K.; Bonior, J.; Szklarczyk, J.; Kot, M.; Konturek, S.J.; Tomaszewska, R.; Pawlik, W.W. Effect of neonatal endotoxemia on the pancreas of adult rats. J. Physiol. Pharmacol., 2008, 59, 87-102.
120. He, L.; Liu, B.; Dai, Z.; Zhang, H.F.; Zhang, Y.S.; Luo, X.J.; Ma, Q.L.; Peng, J. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. Eur. J. Pharmacol., 2012, 678, 32-38.
121. Vindis, C.; Escargueil-Blanc, I.; Uchida, K.; Elbaz, M.; Salvayre, R.; Negre-Salvayre, A. Lipid oxidation products and oxidized lowdensity lipoproteins impair platelet-derived growth factor receptor activity in smooth muscle cells: implication in atherosclerosis. Redox Rep., 2007, 12, 96-100.
122. Biniecka, M.; Kennedy, A.; Ng ,C.T.; Chang, T.C.; Balogh, E.; Fox, E.; Veale, D.J.; Fearon, U.; O'Sullivan, J.N. Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis. Arthritis Res. Ther., 2011, 13, R121.
123. Tammali, R.; Saxena, A.; Srivastava, S.K.; Ramana, K.V. Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle. Endocrinology, 2010, 151, 2140-2150.
124. Spite, M.; Summers, L.; Porter, T.F.; Srivastava, S.; Bhatnagar, A.; Serhan, C.N. Resolvin D1 controls inflammation initiated by glutathione- lipid conjugates formed during oxidative stress. Br. J. Pharmacol., 2009, 158, 1062-1073.
125. Filep, J.G. Lipid mediator interplay: resolvin D1 attenuates inflammation evoked by glutathione-conjugated lipid peroxidation products. Br. J. Pharmacol., 2009, 158, 1059-1061.
126. Tammali, R.; Saxena, A.; Srivastava, S.K.; Ramana, K.V. Aldose reductase inhibition prevents hypoxia-induced increase in hypoxiainducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells. J. Biol. Chem., 2011, 286, 24089-24100.
127. Xiao, T,; Choudhary, S,; Vergara, L.A,; Van Kuijk, FJ,; Ansari, N.H, Oxidative stress -induced formation of 4-hydroxynonenal protein adducts in lens epithelium: Implication in oxidative cataractogenesis. J. Tissue Res., 2004, 4, 181-184.
128. Ohhira, M.; Ohtake, T.; Matsumoto, A.; Saito, H.; Ikuta, K.; Fujimoto, Y.; Ono, M.; Toyokuni, S.; Kohgo, Y. Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in human alcoholic liver diseases. Alcohol Clin. Exp. Res., 1998, 22, 145S-149S.
129. Dalle-Donne, I.; Rossi, R.; Colombo, R.; Giustarini, D.; Milzani, A. Biomarkers of oxidative damage in human disease. Clin. Chem., 2006, 52, 601-623.
130. Trachootham, D.; Lu, W.; Ogasawara, M.A.; Nilsa, R.D.; Huang, P. Redox regulation of cell survival. Antioxid. Redox Signal., 2008, 10, 1343-1374.
131. Ramana, K.V. What is the role of lipid peroxidation product 4- hydroxynonenal in inflammation? Biochem. Anal. Biochem., 2012, doi: 10.4172/2161-1009.1000e105.